Colocalisation of Matrix Metalloproteinase-9-mRNA and Protein in Human Colorectal Cancer Stromal Cells

Overview

Journal Br J Cancer

Specialty Oncology

Date 1996 Oct 1

PMID 8883399

Citations 10

Authors

Z S Zeng

J G Guillem

Affiliations

Soon will be listed here.

Abstract

The matrix metalloproteinases (MMPs) are perceived as essential for tumour invasion and metastases. The purpose of this study was to determine the expression and cellular localisation of the 92 kDa type IV collagenase (MMP-9) protein and mRNA in human colorectal cancer (CRC). In CRC and matched normal mucosa specimens from 26 CRC patients, Northern blot hybridisation and Western blot analyses provide convincing evidence that MMP-9 is expressed in greater quantities in CRC than in normal tissue. The MMP-9 tumour to normal mucosa fold-increase (T/N) was 9.7 +/- 7.1 (mean +/- s.d.) (P < 0.001) for RNA and 7.1 +/- 3.9 (P < 0.001) for protein. The sites of MMP-9 mRNA and protein synthesis were colocalised in tumour stroma by in situ hybridisation and immunohistochemistry in 26 CRC samples. Both MMP-9 mRNA and protein signals were strongest in the population of stromal cells concentrated at the tumour-stroma interface of an invading tumour. Furthermore, MMP-9-positive cells were identified as macrophages using an antimacrophage antibody (KP1) in serial sections from ten CRC samples. Given the persistent localisation of MMP-9-producing macrophages to the interphase between CRC and surrounding stroma, our observations suggest that MMP-9 production is controlled, in part, by tumour-stroma cell interactions. Further studies are needed to determine the in vivo regulation of MMP-9 production from infiltrating peritumour macrophages.

Citing Articles

Berberine as a potential agent for breast cancer therapy.

Zhong X, Chen L, Xu X, Liu Y, Tao F, Zhu M Front Oncol. 2022; 12:993775.

PMID: 36119505 PMC: 9480097. DOI: 10.3389/fonc.2022.993775.

Activated macrophages promote invasion by early colorectal cancer via an interleukin 1β-serum amyloid A1 axis.

Sudo G, Aoki H, Yamamoto E, Takasawa A, Niinuma T, Yoshido A Cancer Sci. 2021; 112(10):4151-4165.

PMID: 34293235 PMC: 8486202. DOI: 10.1111/cas.15080.

Quercetin and sulforaphane in combination suppress the progression of melanoma through the down-regulation of matrix metalloproteinase-9.

Pradhan S, Mishra R, Sharma P, Kundu G Exp Ther Med. 2012; 1(6):915-920.

PMID: 22993618 PMC: 3446732. DOI: 10.3892/etm.2010.144.

Overexpression of matrix metalloproteinase-21 is associated with poor overall survival of patients with colorectal cancer.

Huang Y, Li W, Chu D, Zheng J, Ji G, Li M J Gastrointest Surg. 2011; 15(7):1188-94.

PMID: 21590459 DOI: 10.1007/s11605-011-1519-5.

Berberine suppresses TNF-alpha-induced MMP-9 and cell invasion through inhibition of AP-1 activity in MDA-MB-231 human breast cancer cells.

Kim S, Choi J, Kim J, Nam S, Yang J, Kim J Molecules. 2008; 13(12):2975-85.

PMID: 19052522 PMC: 6244848. DOI: 10.3390/molecules13122975.

References

Young T, Pizzo S, Stack M . A plasma membrane-associated component of ovarian adenocarcinoma cells enhances the catalytic efficiency of matrix metalloproteinase-2. J Biol Chem. 1995; 270(3):999-1002. DOI: 10.1074/jbc.270.3.999. View

Puente X, Pendas A, Llano E, Velasco G, Lopez-Otin C . Molecular cloning of a novel membrane-type matrix metalloproteinase from a human breast carcinoma. Cancer Res. 1996; 56(5):944-9. View

Yu M, Sato H, Seiki M, Thompson E . Complex regulation of membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation by concanavalin A in MDA-MB-231 human breast cancer cells. Cancer Res. 1995; 55(15):3272-7. View

Turpeenniemi-Hujanen T, Thorgeirsson U, Hart I, Grant S, Liotta L . Expression of collagenase IV (basement membrane collagenase) activity in murine tumor cell hybrids that differ in metastatic potential. J Natl Cancer Inst. 1985; 75(1):99-103. View

Yamagata S, Ito Y, Tanaka R, Shimizu S . Gelatinases of metastatic cell lines of murine colonic carcinoma as detected by substrate-gel electrophoresis. Biochem Biophys Res Commun. 1988; 151(1):158-62. DOI: 10.1016/0006-291x(88)90573-6. View

Ballin M, Gomez D, Sinha C, Thorgeirsson U . Ras oncogene mediated induction of a 92 kDa metalloproteinase; strong correlation with the malignant phenotype. Biochem Biophys Res Commun. 1988; 154(3):832-8. DOI: 10.1016/0006-291x(88)90215-x. View

Pulford K, Rigney E, Micklem K, Jones M, Stross W, Gatter K . KP1: a new monoclonal antibody that detects a monocyte/macrophage associated antigen in routinely processed tissue sections. J Clin Pathol. 1989; 42(4):414-21. PMC: 1141915. DOI: 10.1136/jcp.42.4.414. View

Guillem J, Levy M, Hsieh L, Johnson M, LOGERFO P, Forde K . Increased levels of phorbin, c-myc, and ornithine decarboxylase RNAs in human colon cancer. Mol Carcinog. 1990; 3(2):68-74. DOI: 10.1002/mc.2940030204. View

Moll U, Youngleib G, Rosinski K, Quigley J . Tumor promoter-stimulated Mr 92,000 gelatinase secreted by normal and malignant human cells: isolation and characterization of the enzyme from HT1080 tumor cells. Cancer Res. 1990; 50(19):6162-70. View

10.

Nakajima M, Morikawa K, Fabra A, Bucana C, Fidler I . Influence of organ environment on extracellular matrix degradative activity and metastasis of human colon carcinoma cells. J Natl Cancer Inst. 1990; 82(24):1890-8. DOI: 10.1093/jnci/82.24.1890. View

11.

Basset P, Bellocq J, Wolf C, Stoll I, Hutin P, Limacher J . A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature. 1990; 348(6303):699-704. DOI: 10.1038/348699a0. View

12.

Levy A, Cioce V, Sobel M, Garbisa S, Grigioni W, Liotta L . Increased expression of the Mr 72,000 type IV collagenase in human colonic adenocarcinoma. Cancer Res. 1991; 51(1):439-44. View

13.

Liotta L, Steeg P, Stetler-Stevenson W . Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell. 1991; 64(2):327-36. DOI: 10.1016/0092-8674(91)90642-c. View

14.

Muller D, Breathnach R, Engelmann A, Millon R, Bronner G, Flesch H . Expression of collagenase-related metalloproteinase genes in human lung or head and neck tumours. Int J Cancer. 1991; 48(4):550-6. DOI: 10.1002/ijc.2910480412. View

15.

Pyke C, Ralfkiaer E, Huhtala P, Hurskainen T, Dano K, Tryggvason K . Localization of messenger RNA for Mr 72,000 and 92,000 type IV collagenases in human skin cancers by in situ hybridization. Cancer Res. 1992; 52(5):1336-41. View

16.

McDonnell S, Navre M, Coffey Jr R, Matrisian L . Expression and localization of the matrix metalloproteinase pump-1 (MMP-7) in human gastric and colon carcinomas. Mol Carcinog. 1991; 4(6):527-33. DOI: 10.1002/mc.2940040617. View

17.

Poulsom R, Pignatelli M, Stetler-Stevenson W, Liotta L, Wright P, Jeffery R . Stromal expression of 72 kda type IV collagenase (MMP-2) and TIMP-2 mRNAs in colorectal neoplasia. Am J Pathol. 1992; 141(2):389-96. PMC: 1886613. View

18.

Emonard H, Remacle A, Noel A, Grimaud J, Stetler-Stevenson W, Foidart J . Tumor cell surface-associated binding site for the M(r) 72,000 type IV collagenase. Cancer Res. 1992; 52(20):5845-8. View

19.

Matrisian L . The matrix-degrading metalloproteinases. Bioessays. 1992; 14(7):455-63. DOI: 10.1002/bies.950140705. View

20.

Stearns M, Wang M . Type IV collagenase (M(r) 72,000) expression in human prostate: benign and malignant tissue. Cancer Res. 1993; 53(4):878-83. View